CNST - Constellation Pharmaceuticals Inc
Previous close
33.99
0 0%
Share volume: 0
Last Updated: Wed 14 Jul 2021 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$33.99
0.00
0.00%
Summary score
22%
Profitability
25%
Dept financing
4%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-35.1%
Return on assets
-16.69%
Return on sales
0%
Return on invested capital
247.89%
Total debt ratio
23.99%
Debt ratio change over timeo
-0.91%
Current Ratio
10.65%
Quick Ratio
0%
Cash Position Ratio
6.75%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-7.29%
Return on assets
-6.28%
Return on sales
0%
Return on invested capital
226.98%
Total debt ratio
13.75%
Debt ratio change over timeo
-0.95%
Current Ratio
17.69%
Quick Ratio
0%
Cash Position Ratio
8.72%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-7.63%
Return on assets
-6.6%
Return on sales
0%
Return on invested capital
166.46%
Total debt ratio
12.4%
Debt ratio change over time
-0.94%
Current Ratio
15.81%
Quick Ratio
0%
Cash Position Ratio
3.74%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-108%
Return on assets
-106.13%
Return on sales
0%
Return on invested capital
14.02%
Total debt ratio
-91%
Debt ratio change over time
-0.91%
Current Ratio
4.1%
Quick Ratio
0%
Cash Position Ratio
2.03%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CNST | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -35.1% | -3.65% | 12.3% | 6.42% |
| Return on assets | -16.69% | 3.5% | 3.6% | 5.35% |
| Return on sales | 0% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | 247.89% | 4.99% | 7.81% | 13.62% |
| Profitability | 25% | 36% | 68% | 60% |
| Total debt ratio | 23.99% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -0.91% | 224.03% | 6.03% | 1.46% |
| Dept financing | 6% | 50% | 19% | 8% |
| Current Ratio | 17.69% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 8.72% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 16% | 35% | 37% |
| Short-term ratios | CNST | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -7.29% | -16.17% | 18.05% | 7.63% |
| Return on assets | -6.28% | 2.71% | 3.58% | 5.03% |
| Return on sales | 0% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | 226.98% | 6.54% | 5.97% | 19.39% |
| Profitability | 25% | 35% | 68% | 62% |
| Total debt ratio | 13.75% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -0.95% | 851.68% | 10.97% | 0.58% |
| Dept financing | 3% | 50% | 21% | 8% |
| Current Ratio | 17.69% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 8.72% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 24% | 18% | 34% |